Replies to post #62688 on Regen BioPharma Inc (RGBP)

[Skiluc]

Contrary to what some have posted. It is in fact true that Regen has 2 IND issuances on its proprietary studies in its history. Then funding ran out. Not the science.

Wonder what else is getting restored around here?

Clinical Stage biotechnology companies range in the what? 300-600m market cap range?

What a bout a dual clinical stage?

Oopsie.